Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. I. Effect of single doses of polyriboinosinic-polyribocytidylic acid and tilorone hydrochloride on viral pathogenesis

D A Stringfellow et al. J Infect Dis. 1974 Nov.

. 1974 Nov;130(5):470-80.

doi: 10.1093/infdis/130.5.470.

No abstract available

Cited by

Induction of enhanced resistance against encephalomyocarditis virus infection of mice by nonviable Mycobacterium tuberculosis: mechanisms of protection.
Lodmell DL, Ewalt LC. Lodmell DL, et al. Infect Immun. 1978 Dec;22(3):740-5. doi: 10.1128/iai.22.3.740-745.1978. Infect Immun. 1978. PMID: 215550 Free PMC article.
Antiviral activity of BL-3849A, a low-molecular-weight oral interferon inducer.
Kern ER, Hamilton JR, Overall JC, Glasgow LA. Kern ER, et al. Antimicrob Agents Chemother. 1976 Oct;10(4):691-6. doi: 10.1128/AAC.10.4.691. Antimicrob Agents Chemother. 1976. PMID: 185953 Free PMC article.
Antiviral activity of bacteria-derived human alpha interferons against encephalomyocarditis virus infection of mice.
Weck PK, Rinderknecht E, Estell DA, Stebbing N. Weck PK, et al. Infect Immun. 1982 Feb;35(2):660-5. doi: 10.1128/iai.35.2.660-665.1982. Infect Immun. 1982. PMID: 6173327 Free PMC article.
Use of viral infections in animal models to assess changes in the immune system.
Kern ER. Kern ER. Environ Health Perspect. 1982 Feb;43:71-9. doi: 10.1289/ehp.824371. Environ Health Perspect. 1982. PMID: 6174323 Free PMC article.
Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice.
Smee DF, Huffman JH, Gessaman AC, Huggins JW, Sidwell RW. Smee DF, et al. Antiviral Res. 1991 Mar-Apr;15(3):229-39. doi: 10.1016/0166-3542(91)90069-4. Antiviral Res. 1991. PMID: 1716090 Free PMC article.